content

Eisai Co., Ltd. and Wren Therapeutics Ltd. announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery...

Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major depressive disorder (MDD) and postpartum depression (PDD), as well...

AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care. HF...

Lonza AG has announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend,...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...

Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced...

The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has  announced that its Dundalk, Ireland facility has been...